Reflecting on an inspiring SITC2024
November 11, 2024
Dr. Lilian Schoefer
News
News
We had a great time at this year‘s 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2024) in Houston, Texas, sharing our latest advancements in peptide synthesis with the cancer immunotherapy community.
On November 8-9, our CEO Dr. Oliver Kreuzer was at the booth discussing our research peptides and collaboration opportunities. A big thank you to all our visitors, who were exploring our vast collection of cancer/testis antigens and neoantigens – especially to our valued client from the former Rosenberg Group, now AstraZeneca.
On November 8-9, our CEO Dr. Oliver Kreuzer was at the booth discussing our research peptides and collaboration opportunities. A big thank you to all our visitors, who were exploring our vast collection of cancer/testis antigens and neoantigens – especially to our valued client from the former Rosenberg Group, now AstraZeneca.
A highlight were our info cards – “Activating CD4+ and CD8+ T cells: Which peptides match?” – paired with iconic white foam mice, which are almost part of the cultural heritage in Germany. Though some found their red eyes “scary,” the creative combo of mice, elephant-shaped paperclips, and cards was a crowd favorite.
And of course congrats to our lucky elephant raffle winners – check out the smiles!
